Drug Profile


Alternative Names: UP 2696

Latest Information Update: 21 Nov 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator UPSA
  • Class Small molecules
  • Mechanism of Action Angiotensin type 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atherosclerosis; Coronary artery restenosis; Heart failure; Hypertension

Most Recent Events

  • 08 Oct 2001 No-Development-Reported for Atherosclerosis in France (Unknown route)
  • 08 Oct 2001 No-Development-Reported for Coronary artery restenosis in France (Unknown route)
  • 08 Oct 2001 No-Development-Reported for Heart failure in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top